Farther Finance Advisors LLC Boosts Stake in Elevance Health, Inc. $ELV

Farther Finance Advisors LLC increased its position in Elevance Health, Inc. (NYSE:ELV) by 110.4% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 8,607 shares of the company’s stock after purchasing an additional 4,517 shares during the period. Farther Finance Advisors LLC’s holdings in Elevance Health were worth $3,017,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in ELV. Physician Wealth Advisors Inc. lifted its position in shares of Elevance Health by 331.6% in the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock worth $26,000 after buying an additional 63 shares in the last quarter. Activest Wealth Management lifted its position in shares of Elevance Health by 66.7% in the third quarter. Activest Wealth Management now owns 85 shares of the company’s stock worth $27,000 after buying an additional 34 shares in the last quarter. Rossby Financial LCC lifted its position in shares of Elevance Health by 110.0% in the third quarter. Rossby Financial LCC now owns 84 shares of the company’s stock worth $28,000 after buying an additional 44 shares in the last quarter. Motco lifted its position in shares of Elevance Health by 334.8% in the third quarter. Motco now owns 100 shares of the company’s stock worth $32,000 after buying an additional 77 shares in the last quarter. Finally, True Wealth Design LLC lifted its position in shares of Elevance Health by 431.8% in the third quarter. True Wealth Design LLC now owns 117 shares of the company’s stock worth $38,000 after buying an additional 95 shares in the last quarter. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Guggenheim decreased their target price on Elevance Health from $414.00 to $396.00 and set a “buy” rating on the stock in a research report on Thursday, January 29th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $332.00 price objective on shares of Elevance Health in a research report on Thursday, January 29th. Robert W. Baird decreased their price objective on Elevance Health from $340.00 to $317.00 and set a “neutral” rating on the stock in a research report on Wednesday. Weiss Ratings downgraded Elevance Health from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 2nd. Finally, Sanford C. Bernstein decreased their price objective on Elevance Health from $431.00 to $409.00 and set an “outperform” rating on the stock in a research report on Friday, January 30th. Twelve investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Elevance Health currently has a consensus rating of “Hold” and an average price target of $383.57.

Elevance Health Trading Up 2.3%

Shares of ELV stock opened at $323.02 on Friday. The company has a market cap of $70.95 billion, a PE ratio of 12.86, a price-to-earnings-growth ratio of 1.74 and a beta of 0.49. The stock’s 50 day simple moving average is $308.99 and its two-hundred day simple moving average is $331.91. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $432.93. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.54 and a quick ratio of 1.54.

Elevance Health (NYSE:ELV) last released its earnings results on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, beating analysts’ consensus estimates of $3.10 by $0.23. The firm had revenue of $49.31 billion for the quarter, compared to analysts’ expectations of $49.52 billion. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.84 earnings per share. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Research analysts predict that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Elevance Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th were paid a dividend of $1.72 per share. This is a positive change from Elevance Health’s previous quarterly dividend of $1.71. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, March 10th. Elevance Health’s payout ratio is currently 27.39%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.